RA Capital Management Q1 2022 holdings

$4.58 Billion is the total value of RA Capital Management's 96 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 21.6% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A/Ssponsored adr$888,169
-12.8%
7,567,9000.0%19.38%
+8.0%
BIIB NewBIOGEN INC$153,111727,024
+100.0%
3.34%
AVTE  AEROVATE THERAPEUTICS INC$151,479
+55.5%
8,263,9820.0%3.30%
+92.4%
BuyCYTEK BIOSCIENCES INC$144,248
-8.0%
13,381,054
+39.3%
3.15%
+13.9%
ITOS  ITEOS THERAPEUTICS INC$142,147
-30.9%
4,417,2590.0%3.10%
-14.5%
TVTX SellTRAVERE THERAPEUTICS INC$126,864
-27.2%
4,922,941
-12.3%
2.77%
-9.9%
JANX  JANUX THERAPEUTICS INC$124,337
-27.3%
8,670,6440.0%2.71%
-10.0%
PCVX BuyVAXCYTE INC$110,636
+9.7%
4,581,203
+8.0%
2.41%
+35.7%
 ELIEM THERAPEUTICS INC$110,336
-19.8%
13,150,8490.0%2.41%
-0.7%
IMGN BuyIMMUNOGEN INC$103,489
-31.1%
21,741,458
+7.4%
2.26%
-14.7%
 DICE THERAPEUTICS INC$99,646
-24.4%
5,208,9110.0%2.17%
-6.5%
GHRS BuyGH RESEARCH PLCordinary shares$88,292
+33.1%
4,827,330
+69.8%
1.93%
+64.6%
FMTX  FORMA THERAPEUTICS HLDGS INC$83,808
-34.6%
9,011,6510.0%1.83%
-19.0%
 TYRA BIOSCIENCES INC$77,430
-24.0%
7,236,4540.0%1.69%
-5.9%
PNT  POINT BIOPHARMA GLOBAL INC$71,754
+42.3%
9,003,0180.0%1.57%
+76.2%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$70,675
+1.3%
2,075,000
+15.0%
1.54%
+25.4%
BLU  BELLUS HEALTH INC NEW$70,384
-14.5%
10,230,2740.0%1.54%
+5.8%
ENTA NewENANTA PHARMACEUTICALS INC$68,633964,212
+100.0%
1.50%
VOR  VOR BIOPHARMA INC$67,171
-48.0%
11,120,9730.0%1.47%
-35.6%
NKTX  NKARTA INC$63,786
-25.9%
5,605,1290.0%1.39%
-8.2%
MRTX BuyMIRATI THERAPEUTICS INC$60,378
+8.0%
734,343
+92.7%
1.32%
+33.7%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$60,116
-28.2%
6,060,090
+22.0%
1.31%
-11.1%
RYTM  RHYTHM PHARMACEUTICALS INC$56,115
+15.4%
4,871,0670.0%1.22%
+42.8%
NewAN2 THERAPEUTICS INC$55,2573,666,663
+100.0%
1.21%
RLMD  RELMADA THERAPEUTICS INC$53,980
+19.8%
2,000,0000.0%1.18%
+48.4%
MGNX  MACROGENICS INC$53,773
-45.1%
6,103,5940.0%1.17%
-32.1%
NTRA NewNATERA INC$53,3031,310,289
+100.0%
1.16%
TIL  INSTIL BIO INC$52,361
-37.2%
4,870,7930.0%1.14%
-22.3%
NVAX SellNOVAVAX INC$51,024
-83.0%
692,794
-67.0%
1.11%
-79.0%
KNTE BuyKINNATE BIOPHARMA INC$48,014
-24.6%
4,264,144
+18.7%
1.05%
-6.7%
VERA NewVERA THERAPEUTICS INCcl a$46,1831,966,084
+100.0%
1.01%
BuyPARDES BIOSCIENCES INC$44,584
-12.9%
6,175,038
+97.5%
0.97%
+7.8%
BuyICOSAVAX INC$41,983
-68.3%
5,963,565
+3.2%
0.92%
-60.7%
 TENAYA THERAPEUTICS INC$41,837
-37.8%
3,551,5080.0%0.91%
-23.1%
EYPT  EYEPOINT PHARMACEUTICALS INC$40,952
-0.7%
3,370,5060.0%0.89%
+23.0%
GERN  GERON CORP$40,972
+11.5%
30,126,2990.0%0.89%
+38.0%
RNA BuyAVIDITY BIOSCIENCES INC$40,032
+297.6%
2,167,391
+411.6%
0.87%
+390.4%
ABOS  ACUMEN PHARMACEUTICALS INC$38,204
-42.2%
9,770,7730.0%0.83%
-28.4%
 RXSIGHT INC$37,794
+10.0%
3,052,7960.0%0.82%
+36.1%
PMVP  PMV PHARMACEUTICALS INC$35,608
-9.9%
1,710,2650.0%0.78%
+11.5%
DSGN  DESIGN THERAPEUTICS INC$35,314
-24.6%
2,186,6360.0%0.77%
-6.5%
RCKT  ROCKET PHARMACEUTICALS INC$33,419
-27.3%
2,107,1490.0%0.73%
-10.1%
CNTA  CENTESSA PHARMACEUTICALS PLCsponsored ads$32,087
-20.3%
3,577,0940.0%0.70%
-1.4%
GH NewGUARDANT HEALTH INC$31,555476,380
+100.0%
0.69%
ACRS NewACLARIS THERAPEUTICS INC$31,3391,817,808
+100.0%
0.68%
CCXI NewCHEMOCENTRYX INC$28,9801,155,964
+100.0%
0.63%
KALV  KALVISTA PHARMACEUTICALS INC$28,453
+11.4%
1,930,3220.0%0.62%
+38.0%
 LIANBIOsponsored ads$28,400
-39.8%
7,655,0150.0%0.62%
-25.4%
DYN  DYNE THERAPEUTICS INC$27,041
-18.9%
2,805,0450.0%0.59%
+0.3%
VRNA  VERONA PHARMA PLCsponsored ads$25,449
-25.7%
5,100,0000.0%0.56%
-8.1%
EWTX  EDGEWISE THERAPEUTICS INC$25,352
-36.5%
2,613,6230.0%0.55%
-21.4%
STSA  SATSUMA PHARMACEUTICALS INC$22,474
-15.6%
5,914,2520.0%0.49%
+4.5%
CNTB  CONNECT BIOPHARMA HLDGS LTDads$21,113
-41.4%
6,991,0030.0%0.46%
-27.4%
HOWL  WEREWOLF THERAPEUTICS INC$18,884
-63.1%
4,291,8810.0%0.41%
-54.3%
ETNB  89BIO INC$18,721
-71.2%
4,965,7690.0%0.41%
-64.3%
 TANGO THERAPEUTICS INC$17,055
-30.7%
2,250,0000.0%0.37%
-14.3%
RLAY  RELAY THERAPEUTICS INC$16,433
-2.5%
549,0550.0%0.36%
+20.9%
KDNY  CHINOOK THERAPEUTICS INC$16,360
+0.3%
1,000,0000.0%0.36%
+24.0%
SYBX  SYNLOGIC INC$16,000
-0.8%
6,666,6660.0%0.35%
+22.9%
WVE  WAVE LIFE SCIENCES LTD$15,550
-36.3%
7,775,2070.0%0.34%
-21.2%
SCPH SellSCPHARMACEUTICALS INC$15,101
+11.8%
2,658,583
-1.2%
0.33%
+38.2%
KALA  KALA PHARMACEUTICALS INC$15,007
+14.1%
10,874,6130.0%0.33%
+40.9%
SLDB  SOLID BIOSCIENCES INC$14,841
-31.4%
12,367,8730.0%0.32%
-15.2%
ACHL  ACHILLES THERAPEUTICS PLCsponsored ads$14,743
-41.3%
5,014,6870.0%0.32%
-27.3%
 DA32 LIFE SCNCE TEC ACQSTN C$14,573
-1.0%
1,500,0000.0%0.32%
+22.8%
MIST  MILESTONE PHARMACEUTICALS IN$14,423
-2.0%
2,246,5030.0%0.32%
+21.6%
 XILIO THERAPEUTICS INC$14,156
-55.8%
2,002,2170.0%0.31%
-45.3%
GRPH  GRAPHITE BIO INC$13,762
-59.0%
2,698,3690.0%0.30%
-49.2%
OTIC  OTONOMY INC$13,440
+15.4%
5,600,0000.0%0.29%
+42.9%
CYT  CYTEIR THERAPEUTICS INC$12,631
-66.8%
3,350,5060.0%0.28%
-58.9%
BLSA  BCLS ACQUISITION CORP$12,338
+0.7%
1,250,0000.0%0.27%
+24.5%
IPSC  CENTURY THERAPEUTICS INC$11,508
-20.6%
914,0940.0%0.25%
-2.0%
MORF NewMORPHIC HLDG INC$11,197278,874
+100.0%
0.24%
AKUS  AKOUOS INC$10,836
-44.1%
2,281,2490.0%0.24%
-31.0%
CNCE  CONCERT PHARMACEUTICALS INC$10,223
+7.0%
3,033,6030.0%0.22%
+32.7%
FLACU  FRAZIER LIFESCIENCES ACQU CO$9,990
+0.7%
1,000,0000.0%0.22%
+24.6%
 IO BIOTECH INC$9,846
-17.2%
1,857,7550.0%0.22%
+2.4%
 ARYA SCIENCES ACQUISITN$9,710
+0.1%
1,000,0000.0%0.21%
+24.0%
ALVR NewALLOVIR INC$9,7241,440,525
+100.0%
0.21%
 PYXIS ONCOLOGY INC$9,220
-63.2%
2,282,1730.0%0.20%
-54.4%
 ASTRIA THERAPEUTICS INC$8,469
+24.5%
1,262,1930.0%0.18%
+54.2%
FVAM  5 01 ACQUISITION CORP$7,3880.0%750,0000.0%0.16%
+23.8%
BDTX  BLACK DIAMOND THERAPEUTICS I$7,174
-48.0%
2,589,9040.0%0.16%
-35.4%
VERV  VERVE THERAPEUTICS INC$7,081
-38.1%
310,2840.0%0.16%
-23.3%
ORTX  ORCHARD THERAPEUTICS PLCads$6,903
-46.1%
9,694,7890.0%0.15%
-33.2%
ENTX  ENTERA BIO LTD$6,753
+1.9%
2,353,0000.0%0.15%
+25.6%
HSAQ  HEALTH SCIENCES ACQ CORP 2$6,194
-1.7%
625,0000.0%0.14%
+21.6%
LRMR SellLARIMAR THERAPEUTICS INC$5,192
-63.9%
1,281,860
-4.0%
0.11%
-55.5%
 CUE HEALTH INC$4,838
-51.9%
750,0000.0%0.11%
-40.1%
PHAS  PHASEBIO PHARMACEUTICALS INC$3,762
-49.4%
2,850,0000.0%0.08%
-37.4%
CGEM  CULLINAN ONCOLOGY INC$3,665
-32.1%
350,0000.0%0.08%
-15.8%
SellTSCAN THERAPEUTICS INC$2,861
-49.4%
1,021,764
-18.6%
0.06%
-38.0%
BMEA  BIOMEA FUSION INC$2,230
-40.1%
500,0000.0%0.05%
-25.8%
OLMA SellOLEMA PHARMACEUTICALS INC$2,149
-89.3%
504,505
-76.5%
0.05%
-86.8%
CVRX  CVRX INC$1,647
-51.0%
275,0000.0%0.04%
-39.0%
CMPX SellCOMPASS THERAPEUTICS INC$730
-87.5%
532,958
-71.2%
0.02%
-84.5%
SYRS ExitSYROS PHARMACEUTICALS INC$0-900,000
-100.0%
-0.05%
COGT ExitCOGENT BIOSCIENCES INC$0-1,025,641
-100.0%
-0.16%
IKNA ExitIKENA ONCOLOGY INC$0-750,000
-100.0%
-0.17%
SBTX ExitSILVERBACK THERAPEUTICS INC$0-1,742,186
-100.0%
-0.20%
BOLT ExitBOLT BIOTHERAPEUTICS INC$0-2,378,325
-100.0%
-0.20%
NAUT ExitNAUTILUS$0-2,436,430
-100.0%
-0.22%
ExitADAGIO THERAPEUTICS INC$0-4,995,807
-100.0%
-0.64%
TGTX ExitTG THERAPEUTICS INC$0-2,210,145
-100.0%
-0.74%
CCCC ExitC4 THERAPEUTICS INC$0-1,377,569
-100.0%
-0.78%
ZGNX ExitZOGENIX INC$0-3,333,700
-100.0%
-0.96%
PHAT ExitPHATHOM PHARMACEUTICALS INC$0-3,115,008
-100.0%
-1.08%

These EDGAR filings were analyzed to create this holdings report:

The EDGAR filing(s) were signed by:

  • Rajeev Shah — Authorized Signatory

Compare quarterly holdings

Export RA Capital Management's holdings

EDGAR filings